Randomized controlled study on the effects of triple therapy including vonoprazan or rabeprazole for the second-line treatment of Helicobacter pylori infection

BACKGROUND AND AIM: Inhibition of gastric acid secretion is important for eradicating Helicobacter pylori. Vonoprazan (VPZ) is a strong, long-lasting inhibitor of gastric acid secretion. Studies that examined the effectiveness of VPZ-based triple therapy in second-line treatment have been performed....

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Therap Adv Gastroenterol
Auteurs principaux: Hojo, Mariko, Asaoka, Daisuke, Takeda, Tsutomu, Shimada, Yuji, Matsumoto, Kenshi, Matsumoto, Kohei, Yatagai, Noboru, Akazawa, Yoichi, Ueda, Kumiko, Ueyama, Hiroya, Nagahara, Akihito
Format: Artigo
Langue:Inglês
Publié: SAGE Publications 2020
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7675913/
https://ncbi.nlm.nih.gov/pubmed/33240391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284820966247
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires